Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026
Go back to Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.28 +0.41 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.87 | 52 Week High | $108.63 | |||
| Open | $126.63 | 52 Week Low | $71.39 | |||
| Day High | $126.63 | P/E | 69.22 | |||
| Day Low | $124.44 | EPS | $1.81 | |||
| Volume | 4,351,459 | |||||
